Exalenz Bioscience (Modi'in, Israel), a company that specializes in non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, reported new published data supporting the use of its point-of-care BreathID urea breath test for diagnosing Helicobacter pylori infection (H. pylori) in the emergency department (ED) setting. The study was published online in Annals of Emergency Medicine on March 24. Read More
